In AS, PCa is monitoring through prostate-specific antigen (PSA), digital rectal examination (DRE) and biopsies/imaging at specific intervals with management strategies in place should disease progression become evident [11]. This evidence concerns the gene KLK3 and posterior cortical atrophy.